Rapt Therapeutics Inc (NASDAQ:RAPT)

17.59
Delayed Data
As of Dec 02
 +0.07 / +0.40%
Today’s Change
9.86
Today|||52-Week Range
40.74
-52.11%
Year-to-Date

Today’s Trading

Previous close17.52
Today’s open17.30
Day’s range17.30 - 17.95
Volume11,185
Average volume (3 months)327,229
Market cap$607.0M
Data as of 4:00pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)-15.29%
Earnings growth (this year)-1.78%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.38%
P/E ratioNM
Price/Sales263.85
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.19+1.61%
SGMOSangamo Therapeutics...+0.08+2.25%
BNGOBionano Genomics Inc+0.10+5.05%
SRNESorrento Therapeutic...+0.03+2.44%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateMarch 9, 2023
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$3.8M
Annual profit (last year)-$69.2M
Net profit margin-1,814.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts